ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immune Adjuvant Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-25R7739
Home | Market Reports | Health| Pharmacy
Global Immune Adjuvant Market Insights and Forecast to 2028
BUY CHAPTERS

Global Immune Adjuvant Market Research Report 2025

Code: QYRE-Auto-25R7739
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax Inc
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
Abace
Avanti Polar Lipids

Immune Adjuvant Market

The global market for Immune Adjuvant was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immune Adjuvant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Adjuvant.
The Immune Adjuvant market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune Adjuvant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Adjuvant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Immune Adjuvant Market Report

Report Metric Details
Report Name Immune Adjuvant Market
Segment by Type
  • Freund's Adjuvant
  • Cytokine Adjuvants
Segment by Application
  • Research
  • Commercial
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, Abace, Avanti Polar Lipids
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Immune Adjuvant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Immune Adjuvant Market report?

Ans: The main players in the Immune Adjuvant Market are SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue, Aphios, GSK, CSL Limited, Brenntag Biosector, Abace, Avanti Polar Lipids

What are the Application segmentation covered in the Immune Adjuvant Market report?

Ans: The Applications covered in the Immune Adjuvant Market report are Research, Commercial

What are the Type segmentation covered in the Immune Adjuvant Market report?

Ans: The Types covered in the Immune Adjuvant Market report are Freund's Adjuvant, Cytokine Adjuvants

1 Immune Adjuvant Market Overview
1.1 Product Definition
1.2 Immune Adjuvant by Type
1.2.1 Global Immune Adjuvant Market Value Comparison by Type (2024 VS 2031)
1.2.2 Freund's Adjuvant
1.2.3 Cytokine Adjuvants
1.3 Immune Adjuvant by Application
1.3.1 Global Immune Adjuvant Market Value by Application (2024 VS 2031)
1.3.2 Research
1.3.3 Commercial
1.4 Global Immune Adjuvant Market Size Estimates and Forecasts
1.4.1 Global Immune Adjuvant Revenue 2020-2031
1.4.2 Global Immune Adjuvant Sales 2020-2031
1.4.3 Global Immune Adjuvant Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Immune Adjuvant Market Competition by Manufacturers
2.1 Global Immune Adjuvant Sales Market Share by Manufacturers (2020-2025)
2.2 Global Immune Adjuvant Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Immune Adjuvant Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Immune Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Adjuvant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Adjuvant, Product Type & Application
2.7 Global Key Manufacturers of Immune Adjuvant, Date of Enter into This Industry
2.8 Global Immune Adjuvant Market Competitive Situation and Trends
2.8.1 Global Immune Adjuvant Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Immune Adjuvant Players Market Share by Revenue
2.8.3 Global Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immune Adjuvant Market Scenario by Region
3.1 Global Immune Adjuvant Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Immune Adjuvant Sales by Region: 2020-2031
3.2.1 Global Immune Adjuvant Sales by Region: 2020-2025
3.2.2 Global Immune Adjuvant Sales by Region: 2026-2031
3.3 Global Immune Adjuvant Revenue by Region: 2020-2031
3.3.1 Global Immune Adjuvant Revenue by Region: 2020-2025
3.3.2 Global Immune Adjuvant Revenue by Region: 2026-2031
3.4 North America Immune Adjuvant Market Facts & Figures by Country
3.4.1 North America Immune Adjuvant Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Immune Adjuvant Sales by Country (2020-2031)
3.4.3 North America Immune Adjuvant Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immune Adjuvant Market Facts & Figures by Country
3.5.1 Europe Immune Adjuvant Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Immune Adjuvant Sales by Country (2020-2031)
3.5.3 Europe Immune Adjuvant Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Adjuvant Market Facts & Figures by Region
3.6.1 Asia Pacific Immune Adjuvant Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Immune Adjuvant Sales by Region (2020-2031)
3.6.3 Asia Pacific Immune Adjuvant Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Adjuvant Market Facts & Figures by Country
3.7.1 Latin America Immune Adjuvant Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Immune Adjuvant Sales by Country (2020-2031)
3.7.3 Latin America Immune Adjuvant Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Adjuvant Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Adjuvant Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Immune Adjuvant Sales by Country (2020-2031)
3.8.3 Middle East and Africa Immune Adjuvant Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Adjuvant Sales by Type (2020-2031)
4.1.1 Global Immune Adjuvant Sales by Type (2020-2025)
4.1.2 Global Immune Adjuvant Sales by Type (2026-2031)
4.1.3 Global Immune Adjuvant Sales Market Share by Type (2020-2031)
4.2 Global Immune Adjuvant Revenue by Type (2020-2031)
4.2.1 Global Immune Adjuvant Revenue by Type (2020-2025)
4.2.2 Global Immune Adjuvant Revenue by Type (2026-2031)
4.2.3 Global Immune Adjuvant Revenue Market Share by Type (2020-2031)
4.3 Global Immune Adjuvant Price by Type (2020-2031)
5 Segment by Application
5.1 Global Immune Adjuvant Sales by Application (2020-2031)
5.1.1 Global Immune Adjuvant Sales by Application (2020-2025)
5.1.2 Global Immune Adjuvant Sales by Application (2026-2031)
5.1.3 Global Immune Adjuvant Sales Market Share by Application (2020-2031)
5.2 Global Immune Adjuvant Revenue by Application (2020-2031)
5.2.1 Global Immune Adjuvant Revenue by Application (2020-2025)
5.2.2 Global Immune Adjuvant Revenue by Application (2026-2031)
5.2.3 Global Immune Adjuvant Revenue Market Share by Application (2020-2031)
5.3 Global Immune Adjuvant Price by Application (2020-2031)
6 Key Companies Profiled
6.1 SEPPIC
6.1.1 SEPPIC Company Information
6.1.2 SEPPIC Description and Business Overview
6.1.3 SEPPIC Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SEPPIC Immune Adjuvant Product Portfolio
6.1.5 SEPPIC Recent Developments/Updates
6.2 SDA BIO
6.2.1 SDA BIO Company Information
6.2.2 SDA BIO Description and Business Overview
6.2.3 SDA BIO Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SDA BIO Immune Adjuvant Product Portfolio
6.2.5 SDA BIO Recent Developments/Updates
6.3 Croda International Plc
6.3.1 Croda International Plc Company Information
6.3.2 Croda International Plc Description and Business Overview
6.3.3 Croda International Plc Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Croda International Plc Immune Adjuvant Product Portfolio
6.3.5 Croda International Plc Recent Developments/Updates
6.4 SPI Pharma
6.4.1 SPI Pharma Company Information
6.4.2 SPI Pharma Description and Business Overview
6.4.3 SPI Pharma Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SPI Pharma Immune Adjuvant Product Portfolio
6.4.5 SPI Pharma Recent Developments/Updates
6.5 Phibro Animal Health Corporation
6.5.1 Phibro Animal Health Corporation Company Information
6.5.2 Phibro Animal Health Corporation Description and Business Overview
6.5.3 Phibro Animal Health Corporation Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Phibro Animal Health Corporation Immune Adjuvant Product Portfolio
6.5.5 Phibro Animal Health Corporation Recent Developments/Updates
6.6 Tj Kaiwei
6.6.1 Tj Kaiwei Company Information
6.6.2 Tj Kaiwei Description and Business Overview
6.6.3 Tj Kaiwei Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tj Kaiwei Immune Adjuvant Product Portfolio
6.6.5 Tj Kaiwei Recent Developments/Updates
6.7 Novavax
6.7.1 Novavax Company Information
6.7.2 Novavax Description and Business Overview
6.7.3 Novavax Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novavax Immune Adjuvant Product Portfolio
6.7.5 Novavax Recent Developments/Updates
6.8 Zhuoyue
6.8.1 Zhuoyue Company Information
6.8.2 Zhuoyue Description and Business Overview
6.8.3 Zhuoyue Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhuoyue Immune Adjuvant Product Portfolio
6.8.5 Zhuoyue Recent Developments/Updates
6.9 Aphios
6.9.1 Aphios Company Information
6.9.2 Aphios Description and Business Overview
6.9.3 Aphios Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aphios Immune Adjuvant Product Portfolio
6.9.5 Aphios Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Immune Adjuvant Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 CSL Limited
6.11.1 CSL Limited Company Information
6.11.2 CSL Limited Description and Business Overview
6.11.3 CSL Limited Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CSL Limited Immune Adjuvant Product Portfolio
6.11.5 CSL Limited Recent Developments/Updates
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Company Information
6.12.2 Brenntag Biosector Description and Business Overview
6.12.3 Brenntag Biosector Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Brenntag Biosector Immune Adjuvant Product Portfolio
6.12.5 Brenntag Biosector Recent Developments/Updates
6.13 Abace
6.13.1 Abace Company Information
6.13.2 Abace Description and Business Overview
6.13.3 Abace Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abace Immune Adjuvant Product Portfolio
6.13.5 Abace Recent Developments/Updates
6.14 Avanti Polar Lipids
6.14.1 Avanti Polar Lipids Company Information
6.14.2 Avanti Polar Lipids Description and Business Overview
6.14.3 Avanti Polar Lipids Immune Adjuvant Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Avanti Polar Lipids Immune Adjuvant Product Portfolio
6.14.5 Avanti Polar Lipids Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Adjuvant Industry Chain Analysis
7.2 Immune Adjuvant Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Adjuvant Production Mode & Process Analysis
7.4 Immune Adjuvant Sales and Marketing
7.4.1 Immune Adjuvant Sales Channels
7.4.2 Immune Adjuvant Distributors
7.5 Immune Adjuvant Customer Analysis
8 Immune Adjuvant Market Dynamics
8.1 Immune Adjuvant Industry Trends
8.2 Immune Adjuvant Market Drivers
8.3 Immune Adjuvant Market Challenges
8.4 Immune Adjuvant Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax Inc
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
Abace
Avanti Polar Lipids
List of Tables
 Table 1. Global Immune Adjuvant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Immune Adjuvant Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Immune Adjuvant Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Immune Adjuvant Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Immune Adjuvant Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Immune Adjuvant Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Immune Adjuvant Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Immune Adjuvant Average Price (US$/KG) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Immune Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Immune Adjuvant, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Immune Adjuvant, Product Type & Application
 Table 12. Global Key Manufacturers of Immune Adjuvant, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Immune Adjuvant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Adjuvant as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Immune Adjuvant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Immune Adjuvant Sales by Region (2020-2025) & (KG)
 Table 18. Global Immune Adjuvant Sales Market Share by Region (2020-2025)
 Table 19. Global Immune Adjuvant Sales by Region (2026-2031) & (KG)
 Table 20. Global Immune Adjuvant Sales Market Share by Region (2026-2031)
 Table 21. Global Immune Adjuvant Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Immune Adjuvant Revenue Market Share by Region (2020-2025)
 Table 23. Global Immune Adjuvant Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Immune Adjuvant Revenue Market Share by Region (2026-2031)
 Table 25. North America Immune Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Immune Adjuvant Sales by Country (2020-2025) & (KG)
 Table 27. North America Immune Adjuvant Sales by Country (2026-2031) & (KG)
 Table 28. North America Immune Adjuvant Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Immune Adjuvant Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Immune Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Immune Adjuvant Sales by Country (2020-2025) & (KG)
 Table 32. Europe Immune Adjuvant Sales by Country (2026-2031) & (KG)
 Table 33. Europe Immune Adjuvant Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Immune Adjuvant Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Immune Adjuvant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Immune Adjuvant Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Immune Adjuvant Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Immune Adjuvant Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Immune Adjuvant Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Immune Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Immune Adjuvant Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Immune Adjuvant Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Immune Adjuvant Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Immune Adjuvant Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Immune Adjuvant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Immune Adjuvant Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Immune Adjuvant Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Immune Adjuvant Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Immune Adjuvant Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Immune Adjuvant Sales (KG) by Type (2020-2025)
 Table 51. Global Immune Adjuvant Sales (KG) by Type (2026-2031)
 Table 52. Global Immune Adjuvant Sales Market Share by Type (2020-2025)
 Table 53. Global Immune Adjuvant Sales Market Share by Type (2026-2031)
 Table 54. Global Immune Adjuvant Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Immune Adjuvant Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Immune Adjuvant Revenue Market Share by Type (2020-2025)
 Table 57. Global Immune Adjuvant Revenue Market Share by Type (2026-2031)
 Table 58. Global Immune Adjuvant Price (US$/KG) by Type (2020-2025)
 Table 59. Global Immune Adjuvant Price (US$/KG) by Type (2026-2031)
 Table 60. Global Immune Adjuvant Sales (KG) by Application (2020-2025)
 Table 61. Global Immune Adjuvant Sales (KG) by Application (2026-2031)
 Table 62. Global Immune Adjuvant Sales Market Share by Application (2020-2025)
 Table 63. Global Immune Adjuvant Sales Market Share by Application (2026-2031)
 Table 64. Global Immune Adjuvant Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Immune Adjuvant Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Immune Adjuvant Revenue Market Share by Application (2020-2025)
 Table 67. Global Immune Adjuvant Revenue Market Share by Application (2026-2031)
 Table 68. Global Immune Adjuvant Price (US$/KG) by Application (2020-2025)
 Table 69. Global Immune Adjuvant Price (US$/KG) by Application (2026-2031)
 Table 70. SEPPIC Company Information
 Table 71. SEPPIC Description and Business Overview
 Table 72. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 73. SEPPIC Immune Adjuvant Product
 Table 74. SEPPIC Recent Developments/Updates
 Table 75. SDA BIO Company Information
 Table 76. SDA BIO Description and Business Overview
 Table 77. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 78. SDA BIO Immune Adjuvant Product
 Table 79. SDA BIO Recent Developments/Updates
 Table 80. Croda International Plc Company Information
 Table 81. Croda International Plc Description and Business Overview
 Table 82. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 83. Croda International Plc Immune Adjuvant Product
 Table 84. Croda International Plc Recent Developments/Updates
 Table 85. SPI Pharma Company Information
 Table 86. SPI Pharma Description and Business Overview
 Table 87. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 88. SPI Pharma Immune Adjuvant Product
 Table 89. SPI Pharma Recent Developments/Updates
 Table 90. Phibro Animal Health Corporation Company Information
 Table 91. Phibro Animal Health Corporation Description and Business Overview
 Table 92. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 93. Phibro Animal Health Corporation Immune Adjuvant Product
 Table 94. Phibro Animal Health Corporation Recent Developments/Updates
 Table 95. Tj Kaiwei Company Information
 Table 96. Tj Kaiwei Description and Business Overview
 Table 97. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 98. Tj Kaiwei Immune Adjuvant Product
 Table 99. Tj Kaiwei Recent Developments/Updates
 Table 100. Novavax Company Information
 Table 101. Novavax Description and Business Overview
 Table 102. Novavax Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 103. Novavax Immune Adjuvant Product
 Table 104. Novavax Recent Developments/Updates
 Table 105. Zhuoyue Company Information
 Table 106. Zhuoyue Description and Business Overview
 Table 107. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 108. Zhuoyue Immune Adjuvant Product
 Table 109. Zhuoyue Recent Developments/Updates
 Table 110. Aphios Company Information
 Table 111. Aphios Description and Business Overview
 Table 112. Aphios Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 113. Aphios Immune Adjuvant Product
 Table 114. Aphios Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 118. GSK Immune Adjuvant Product
 Table 119. GSK Recent Developments/Updates
 Table 120. CSL Limited Company Information
 Table 121. CSL Limited Description and Business Overview
 Table 122. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 123. CSL Limited Immune Adjuvant Product
 Table 124. CSL Limited Recent Developments/Updates
 Table 125. Brenntag Biosector Company Information
 Table 126. Brenntag Biosector Description and Business Overview
 Table 127. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 128. Brenntag Biosector Immune Adjuvant Product
 Table 129. Brenntag Biosector Recent Developments/Updates
 Table 130. Abace Company Information
 Table 131. Abace Description and Business Overview
 Table 132. Abace Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 133. Abace Immune Adjuvant Product
 Table 134. Abace Recent Developments/Updates
 Table 135. Avanti Polar Lipids Company Information
 Table 136. Avanti Polar Lipids Description and Business Overview
 Table 137. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
 Table 138. Avanti Polar Lipids Immune Adjuvant Product
 Table 139. Avanti Polar Lipids Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Immune Adjuvant Distributors List
 Table 143. Immune Adjuvant Customers List
 Table 144. Immune Adjuvant Market Trends
 Table 145. Immune Adjuvant Market Drivers
 Table 146. Immune Adjuvant Market Challenges
 Table 147. Immune Adjuvant Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Immune Adjuvant
 Figure 2. Global Immune Adjuvant Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Immune Adjuvant Market Share by Type: 2024 & 2031
 Figure 4. Freund's Adjuvant Product Picture
 Figure 5. Cytokine Adjuvants Product Picture
 Figure 6. Global Immune Adjuvant Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Immune Adjuvant Market Share by Application: 2024 & 2031
 Figure 8. Research
 Figure 9. Commercial
 Figure 10. Global Immune Adjuvant Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Immune Adjuvant Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Immune Adjuvant Sales (2020-2031) & (KG)
 Figure 13. Global Immune Adjuvant Average Price (US$/KG) & (2020-2031)
 Figure 14. Immune Adjuvant Report Years Considered
 Figure 15. Immune Adjuvant Sales Share by Manufacturers in 2024
 Figure 16. Global Immune Adjuvant Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Immune Adjuvant Players: Market Share by Revenue in Immune Adjuvant in 2024
 Figure 18. Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Immune Adjuvant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Immune Adjuvant Sales Market Share by Country (2020-2031)
 Figure 21. North America Immune Adjuvant Revenue Market Share by Country (2020-2031)
 Figure 22. United States Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Immune Adjuvant Sales Market Share by Country (2020-2031)
 Figure 25. Europe Immune Adjuvant Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Immune Adjuvant Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Immune Adjuvant Revenue Market Share by Region (2020-2031)
 Figure 33. China Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Immune Adjuvant Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Immune Adjuvant Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Immune Adjuvant Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Immune Adjuvant Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Immune Adjuvant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Immune Adjuvant by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Immune Adjuvant by Type (2020-2031)
 Figure 54. Global Immune Adjuvant Price (US$/KG) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Immune Adjuvant by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Immune Adjuvant by Application (2020-2031)
 Figure 57. Global Immune Adjuvant Price (US$/KG) by Application (2020-2031)
 Figure 58. Immune Adjuvant Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Human Vaccine Adjuvants Market
Global Health Product for Immune Market Research Report 2024
Global Adjuvants in Agriculture Market Research Report 2024
Global Adjuvant Therapy Market Research Report 2024
Global Immune System Booster Market Research Report 2024
Global Biological Vaccines Adjuvants Market Research Report 2025
Global Immunological Agents Market Research Report 2024
Global Immune Checkpoint Agents Market Research Report 2025
Global Tumor Immunity Therapy Market Research Report 2024
Global Immunity Boosting Food Market Research Report 2024
Global Fungicide Adjuvants Market Research Report 2025
Global Agricultural Utility Adjuvants Market Research Report 2025
Global Immune Boosting Health Products Market Research Report 2024
Global Utility Agricultural Adjuvants Market Research Report 2025
Global Oral Vaccine Adjuvants Market Research Report 2025
Global Vaccine Particulate Adjuvants Market Research Report 2025
Global Food Allergy Vaccine Market Research Report 2024
Global Agricultural Spray Adjuvant Agents Market Research Report 2025
Global Surfactant Cleansers and Adjuvants Market Research Report 2024
Global Agriculture Fungicide Adjuvants Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions